Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
medroxyprogesterone
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(5)
News
Trials
Company:
Generic mfg.
Drug class:
Progesterone receptor agonist
Related drugs:
‹
megestrol (7)
megestrol (7)
›
Associations
(5)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Endometrial Cancer
No biomarker
Endometrial Cancer
tamoxifen + medroxyprogesterone
Sensitive: A2 - Guideline
tamoxifen + medroxyprogesterone
Sensitive
:
A2
tamoxifen + medroxyprogesterone
Sensitive: A2 - Guideline
tamoxifen + medroxyprogesterone
Sensitive
:
A2
No biomarker
Endometrial Cancer
No biomarker
Endometrial Cancer
medroxyprogesterone
Sensitive: A2 - Guideline
medroxyprogesterone
Sensitive
:
A2
medroxyprogesterone
Sensitive: A2 - Guideline
medroxyprogesterone
Sensitive
:
A2
PGR positive
Uterine Corpus Leiomyosarcoma
PGR positive
Uterine Corpus Leiomyosarcoma
medroxyprogesterone
Sensitive: A2 - Guideline
medroxyprogesterone
Sensitive
:
A2
medroxyprogesterone
Sensitive: A2 - Guideline
medroxyprogesterone
Sensitive
:
A2
ER positive
Uterine Corpus Leiomyosarcoma
ER positive
Uterine Corpus Leiomyosarcoma
medroxyprogesterone
Sensitive: A2 - Guideline
medroxyprogesterone
Sensitive
:
A2
medroxyprogesterone
Sensitive: A2 - Guideline
medroxyprogesterone
Sensitive
:
A2
HR positive
Soft Tissue Sarcoma
HR positive
Soft Tissue Sarcoma
medroxyprogesterone
Sensitive: A2 - Guideline
medroxyprogesterone
Sensitive
:
A2
medroxyprogesterone
Sensitive: A2 - Guideline
medroxyprogesterone
Sensitive
:
A2
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login